Neonatal sepsis, a condition caused by the body’s response to infections, affects four million newborns globally every year. It makes up 15% of all neonatal deaths and the majority occur in low-income countries. Alarmingly, and further complicating an already lethal condition, up to 40% of neonatal sepsis cases are due to resistant pathogens. Today, on World Children's Day, ReAct releases a new report on newborns, sepsis and antibiotic resistance.
Over 400 responses from 74 countries
ReAct conducted a web-based survey between July 29th – October15th, 2020 aiming to understand the awareness, availability of guidelines, general practice and potential challenges physicians face around neonatal sepsis and antimicrobial resistance. Over 400 responses from 74 countries were received.
- Overall, 60% of respondents are very or even extremely worried about antimicrobial resistance as a threat to the effective treatment of neonatal sepsis.
- 79% of respondents have seen an increasing trend of multidrug resistant infections over the last five years, regardless of the region and income level of the health care facility where they work.
- In some low-income countries, physicians report that over 50% of the newborns they treat develop sepsis and that over 75% of neonatal sepsis cases are due to resistant pathogens.
“We need availability of national regulatory policy, periodic research and study to map the profile and extent of antimicrobial resistance in the nation, use the data for preparation of national guidelines and protocols, including IPC, training and orientation of health service providers within and outside the hospitals including in the private sector and awareness creation in the general public.”
Physician, Sierra Leone
Five recommendations from report
The following actions can have an impact on antimicrobial resistance and neonatal sepsis:
- Policy changes and strong commitments from governments
- Improving awareness of neonatal sepsis and antimicrobial resistance among hospital staff
- Antimicrobial stewardship and Infection Prevention and Control
- Availability of effective existing and new antibiotics
- Availability of diagnostics and improving lab capacity
Life-threatening infections in children are becoming untreatable. Leaders – act now! For a world free from untreatable infections. #AntibioticResistance Tweet this
The message is clear – physicians are worried about losing the very drugs that can save the lives of newborns with sepsis. Leaders – act now! For a world free from untreatable infections. #AntibioticResistance Tweet this
More news and opinion from 2020
- Nurse Dorce, Indonesia: Treating small patients with much love and infection prevention – a success story
- ReAct highlights during World Antimicrobial Awareness week 2020
- ReAct Asia Pacific: Winners of 2020 photography competition
- WAAW ReAct Africa: Engaging civil society and students
- WAAW in Indonesia: Focus on One Health approach to AMR
- Innovate4Health’s 32 finalist teams: For social innovations to address emerging infectious diseases!
- ReAct Open Letter: 5 key points to One Health Global Leaders Group on Antimicrobial Resistance
- New ReAct Report: Treatment of newborn sepsis is threatened – effective antibiotics essential
- Upcoming ReAct Africa Conference: What is the status of the NAPs on AMR in the African region?
- Animal welfare and antibiotic resistance in food animals
- ReAct activities for World Antimicrobial Awareness Week 2020
- Dr. Honar Cherif: My patients can receive 5-10 courses of antibiotics during their cancer treatment
- New ReAct Report: Antibiotic resistance affects men and women differently
- ReAct Asia Pacific: Photo competition for students – health in focus
- 4 take aways from WHO’s first global report on sepsis
- Launch of global student design sprint – Innovate4Health
- World Sepsis Day – antibiotics essential in treatment of sepsis
- The new Pharmaceutical Strategy for Europe – an opportunity to put public interest first
- 4 key reflections on the recently launched WHO GLASS-report
- Key points from ReAct’s comments to the Independent Panel on Evidence
- ReAct Interview: From zoologist to community engagement on AMR
- ReAct Africa expands
- COVID-19 resolution – a missed opportunity to address global pandemic response more broadly
- What everyone needs to know about clinical research
- New ReAct Policy Brief: Successful cancer treatment relies on effective antibiotics
- Impact of COVID-19 on vaccine-preventable diseases and antibiotic resistance
- ReAct Africa and Africa CDC: COVID-19 webinars
- Antibiotic pollution: India scores a global first with effluent limits
- COVID-19 and AMR – what do we know so far?
- Learning from bedaquiline in South Africa – comprehensive health systems for new antibiotics
- ReAct Interview: How does antibiotics in food animal production end up in the environment?
- Key take aways from CSO workshop on AMR in Kenya
- New fact sheet: Effective antibiotics – essential for childrens’ survival
- Shortages and AMR – why should we care? 4 consequences of antibiotic shortages
- Our microbiome and noncommunicable diseases
- The 2020 AMR Benchmark Report – concerning findings with questionable framing
- 4 key reflections from engaging hospitals in India for antibiotic stewardship
- Teacher Gustavo Cedillo, Ecuador, teaches children about the bacterial world